| NCT06602271 | PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301) | NOT_YET_RECRUITING | PHASE3 | 2025-03 | 2026-04 | 2026-03 |
| NCT06500793 | Single and Multi-Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102) | RECRUITING | PHASE1 | 2024-11-24 | 2026-03-27 | 2026-01-30 |
| NCT06629402 | Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201) | COMPLETED | PHASE2 | 2023-10-05 | 2023-11-15 | 2023-11-14 |
| NCT05571345 | A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104) | COMPLETED | PHASE1 | 2022-10-05 | 2022-12-28 | 2022-12-23 |
| NCT05567354 | A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103) | COMPLETED | PHASE1 | 2022-06-10 | 2022-08-31 | 2022-08-31 |
| NCT05090280 | Pharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101) | COMPLETED | PHASE1 | 2021-12-01 | 2023-04-26 | 2023-04-26 |
| NCT05043766 | Evaluation of Oral PF614 Relative to OxyContin (PF614-102) | COMPLETED | PHASE1 | 2021-09-08 | 2022-03-21 | 2022-03-21 |
| NCT04406415 | Oral Nafamostat in Healthy Volunteers (NAF-101) | COMPLETED | PHASE1 | 2020-09-21 | 2021-05-14 | 2020-11-11 |
| NCT02454712 | Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101) | COMPLETED | PHASE1 | 2016-11-16 | 2018-01-18 | 2018-01-18 |